PTC Therapeutics | PTCT - Trade Debtors


PTC Therapeutics reported $196.13M in Trade Debtors for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 2.63B
Cash and Equivalent USD 1.02B
Cost of Sales USD 15.48M
Current Assets USD 2.27B
Current Liabilities USD 627.81M
Debt USD 286.01M
EBIT USD -34.86M
EBITDA USD 971.14M
Employees 939
EPS Earnings Per Share USD -0.83
Equity Capital and Reserves USD -206.55M
Gross Profit on Sales USD 163.39M
Interest Expense on Debt USD 30.36M
Loan Capital USD 2.13B
Market Capitalization USD 4.34B
Net Income USD -64.85M
Operating Expenses USD 213.73M
Operating Profit USD -34.86M
Ordinary Share Capital USD 79.38M
PE Price to Earnings USD 6.47
Pre-Tax Profit USD -71.05M
Sales Revenues USD 178.9M
Selling and Administration Expenses USD 85.26M
Stock USD 34.06M
Trade Creditors USD 206.31M
Trade Debtors USD 196.13M

Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amgen USD 8.7B 569M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Cytokinetics USD 8.41M 6.4M Jun/2025
Daiichi Sankyo JPY 611.76B 7.34B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Novartis USD 9.18B 451M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
TG Therapeutics USD 231.52M 102.33M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025
Xencor USD 47.55M 9.77M Jun/2025